(Q27086849)

MK-5108 (English)

3 October 2016

C₂₂H₂₁ClFN₃O₃S

1 reference

MK-5108 (English)

3 October 2016

C1CC(CCC1OC2=C(C(=CC=C2)Cl)F)(CC3=NC(=CC=C3)NC4=NC=CS4)C(=O)O

1 reference

MK-5108 (English)

physically interacts with

3 October 2016

1 reference

Open Targets Platform

https://platform.opentargets.org/drug/CHEMBL3182444

14 August 2023

reference URL

Identifiers

InChI

InChI=1S/C22H21ClFN3O3S/c23-16-4-2-5-17(19(16)24)30-15-7-9-22(10-8-15,20(28)29)13-14-3-1-6-18(26-14)27-21-25-11-12-31-21/h1-6,11-12,15H,7-10,13H2,(H,28,29)(H,25,26,27)

1 reference

LCVIRAZGMYMNNT-UHFFFAOYSA-N

MK-5108 (English)

3 October 2016

2 references

MK-5108 (English)

3 October 2016

ChEBI release 2020-09-01

1 reference

4-(3-Chloro-2-fluorophenoxy)-1-{[6-(1,3-thiazol-2-ylamino)-2-pyridinyl]methyl}cyclohexanecarboxylic acid (English)

3 October 2016

2 references

MK-5108 (English)

matched by identifier from

3 October 2016

InChIKey

LCVIRAZGMYMNNT-UHFFFAOYSA-N

ChEBI ID

125340

mapping relation type

2 references

4-(3-chloro-2-fluorophenoxy)-1-[[6-(2-thiazolylamino)-2-pyridinyl]methyl]-1-cyclohexanecarboxylic acid (English)

matched by identifier from

3 October 2016

International Chemical Identifier

InChI

InChI=1S/C22H21ClFN3O3S/c23-16-4-2-5-17(19(16)24)30-15-7-9-22(10-8-15,20(28)29)13-14-3-1-6-18(26-14)27-21-25-11-12-31-21/h1-6,11-12,15H,7-10,13H2,(H,28,29)(H,25,26,27)

1 reference

Guide to Pharmacology Ligand ID

MK-5108 (English)

3 October 2016

1 reference

8061

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

8061